These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inflammatory bowel disease and the risk of osteoporosis and fracture. Targownik LE; Bernstein CN; Leslie WD Maturitas; 2013 Dec; 76(4):315-9. PubMed ID: 24139749 [TBL] [Abstract][Full Text] [Related]
4. Management of bone loss in inflammatory bowel disease. Lichtenstein GR Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081 [TBL] [Abstract][Full Text] [Related]
6. Osteoporosis in inflammatory bowel disease. Ali T; Lam D; Bronze MS; Humphrey MB Am J Med; 2009 Jul; 122(7):599-604. PubMed ID: 19559158 [TBL] [Abstract][Full Text] [Related]
7. Review article: bone disease in inflammatory bowel disease. Schulte CM Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():43-9. PubMed ID: 15352893 [TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. Katz S Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475 [TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Valentine JF; Sninsky CA Am J Gastroenterol; 1999 Apr; 94(4):878-83. PubMed ID: 10201450 [TBL] [Abstract][Full Text] [Related]
12. Osteoporosis in inflammatory bowel disease. Matsuura M Nihon Rinsho; 2017 Mar; 75(3):466-470. PubMed ID: 30566793 [TBL] [Abstract][Full Text] [Related]
13. The frequency of osteoporosis screening in men with inflammatory bowel disease. Nguyen HD; Bakshi AK; Borum ML Am J Mens Health; 2010 Mar; 4(1):71-4. PubMed ID: 19477762 [TBL] [Abstract][Full Text] [Related]
14. Corticosteroid-induced bone loss. Prevention and management. Picado C; Luengo M Drug Saf; 1996 Nov; 15(5):347-59. PubMed ID: 8941496 [TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087 [TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in rheumatoid arthritis. Jones SM; Bhalla AK Clin Exp Rheumatol; 1993; 11(5):557-62. PubMed ID: 8275594 [TBL] [Abstract][Full Text] [Related]
17. All patients with inflammatory bowel disease should have bone density assessment: pro. Papaioannou A; Ferko NC; Adachi JD Inflamm Bowel Dis; 2001 May; 7(2):158-62; discussion 168-9. PubMed ID: 11383589 [TBL] [Abstract][Full Text] [Related]
18. [Osteoporosis in chronic inflammatory bowel diseases--what is the value of fluoride therapy? Symposium: "Osteopenia, osteoporosis in chronic inflammatory bowel diseases". Saalfelden, 10 October 1998]. Dtsch Med Wochenschr; 1998 Dec; 123(51-52 Suppl Osteoporos):1-4. PubMed ID: 9894480 [No Abstract] [Full Text] [Related]
20. Bone mineral density evaluation by physicians in patients with inflammatory bowel disease: differences based on corticosteroid use. Thanjan AJ; Tishon JR; Borum ML Am J Gastroenterol; 2006 Nov; 101(11):2669-70. PubMed ID: 17090293 [No Abstract] [Full Text] [Related] [Next] [New Search]